Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.016 | 0.7 |